The effect of ezetimibe on serum lipids and lipoproteins in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis therapy
- 31 May 2006
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 186 (1) , 126-131
- https://doi.org/10.1016/j.atherosclerosis.2005.06.039
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Plasmapheresis for Prevention and Regression of Coronary AtherosclerosisAnnals of the New York Academy of Sciences, 2006
- Treatment of High-Risk patients with ezetimibe plus simvastatin Co-Administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III Low-Density lipoprotein cholesterol goalsThe American Journal of Cardiology, 2004
- Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol AbsorptionScience, 2004
- Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary HypercholesterolemiaCirculation, 2003
- EzetimibeDrugs of Today, 2003
- Efficacy and Safety of Ezetimibe Coadministered With Atorvastatin or Simvastatin in Patients With Homozygous Familial HypercholesterolemiaCirculation, 2002
- Siblings with normal LDL receptor activity and severe hypercholesterolemia.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1985
- Effects of probucol on homozygous cases of familial hypercholesterolemiaAtherosclerosis, 1983
- Therapeutic effects of ML-236B in primary hypercholesterolemiaAtherosclerosis, 1980